![Nicola Broughton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicola Broughton
Oprichter bij
Oskare Capital SAS
Profiel
Nicola Broughton is the founder of Oskare Capital SAS, serving as Co- Venture Partner since 2020.
Current jobs include Non Executive Director at Cytomos Ltd. since 2022, Managing Director at Dr. Broughton Consulting Ltd. since 2020, Board Member at QUBIS Ltd. since 2022, Chief Business Officer at Cumulus Oncology Ltd. since 2021, Chief Business Officer at Nodus Oncology Ltd. since 2022, Venture Partner at Old College Capital since 2023, and Venture Partner at Edinburgh Technology Fund Ltd. Former jobs include Chairman at Wobble Genomics Ltd., Commercial Director at Photopharmica Ltd. from 2002 to 2012, Investment Director at Mercia Fund Management Ltd., Non Executive Director at Tozaro Ltd. from 2015 to 2020, Non Executive Director at In-Part Publishing Ltd. from 2019 to 2020, Non Executive Director at Manchester Imaging Ltd. from 2016 to 2018, Non Executive Director at Medherant Ltd. from 2015 to 2018, and Non Executive Director at Invizius Ltd. from 2018 to 2020.
Education includes an undergraduate degree from the University of Oxford conferred in 1994, an MBA from the University of Northumbria conferred in 2000, and a doctorate from King's College London conferred in 1998.
Actieve functies van Nicola Broughton
| Bedrijven | Functie | Begin |
|---|---|---|
QUBIS Ltd.
 QUBIS Ltd. Investment ManagersFinance Qubis invests in companies located in the United Kingdom. The firm targets companies operating in the fields of digital, engineering, environmental, scientific and life science sectors. It provides financing for seed and early stage capital requirements. | Directeur/Bestuurslid | 05-07-2022 |
Nodus Oncology Ltd.
 Nodus Oncology Ltd. BiotechnologyHealth Technology Develops DDR targeting therapies | Corporate Officer/Principal | 01-09-2022 |
Cumulus Oncology Ltd.
 Cumulus Oncology Ltd. Pharmaceuticals: MajorHealth Technology Develops oncology drugs | Corporate Officer/Principal | 01-07-2020 |
Cytomos Ltd.
 Cytomos Ltd. Miscellaneous Commercial ServicesCommercial Services Provides rapid label-free cell analysis for biotech research and in-vitro diagnostics using dielectric spectroscopy | Directeur/Bestuurslid | 01-01-2022 |
Oskare Capital SAS
 Oskare Capital SAS Investment ManagersFinance Oskare Capital SAS is an active manager that invests in Europe. | Oprichter | 01-06-2020 |
Nicola Broughton Consulting Ltd. | Private Equity Investor | 01-05-2020 |
Old College Capital
 Old College Capital Investment ManagersFinance Old College Capital LP seeks investment opportunities in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It provides financing for early and growth transactions to universities leading spin out and start up companies. It also makes co-investments. | Private Equity Investor | 01-08-2023 |
Edinburgh Technology Fund Ltd.
 Edinburgh Technology Fund Ltd. Investment ManagersFinance Edinburgh Technology Fund invests in companies located in the United Kingdom. The firm targets companies operating in the fields of life science and medicine, informatics and digital technologies, engineering, energy and circular economy. It provides financing for pres-seed and early stage and spinout capital requirements. | Private Equity Investor | - |
Eerdere bekende functies van Nicola Broughton
| Bedrijven | Functie | Einde |
|---|---|---|
MIP Discovery Ltd. (United Kingdom)
 MIP Discovery Ltd. (United Kingdom) BiotechnologyHealth Technology Develops and manufactures viral vectors in cell & gene therapy | Directeur/Bestuurslid | 01-05-2020 |
| ░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Nicola Broughton
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
55
Eerstegraads connecties
19
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 19 |
|---|---|
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
QUBIS Ltd.
QUBIS Ltd. Investment ManagersFinance Qubis invests in companies located in the United Kingdom. The firm targets companies operating in the fields of digital, engineering, environmental, scientific and life science sectors. It provides financing for seed and early stage capital requirements. | Finance |
Photopharmica Ltd.
 Photopharmica Ltd. Medical SpecialtiesHealth Technology Develops and discovers novel photosensitizer products | Health Technology |
University of Northumbria
 University of Northumbria Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
King's College London
 King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mercia Fund Management Ltd.
 Mercia Fund Management Ltd. Investment ManagersFinance Mercia Fund invests in companies located in the United Kingdom. The firm targets companies operating in a broad range of sectors. It provides financing for seed, early and growth stage capital requirements. The firm also participates in MBOs, buy-in, acquisition financing, debt, and mezzanine transactions with an investment size of GBP 1 - 10 million. It also acquires minority investments. | Finance |
Edinburgh Technology Fund Ltd.
Edinburgh Technology Fund Ltd. Investment ManagersFinance Edinburgh Technology Fund invests in companies located in the United Kingdom. The firm targets companies operating in the fields of life science and medicine, informatics and digital technologies, engineering, energy and circular economy. It provides financing for pres-seed and early stage and spinout capital requirements. | Finance |
MIP Discovery Ltd. (United Kingdom)
MIP Discovery Ltd. (United Kingdom) BiotechnologyHealth Technology Develops and manufactures viral vectors in cell & gene therapy | Health Technology |
In-Part Publishing Ltd.
 In-Part Publishing Ltd. Packaged SoftwareTechnology Services Develops digital matchmaking platforms dedicated to academia industry collaboration | Technology Services |
Old College Capital
Old College Capital Investment ManagersFinance Old College Capital LP seeks investment opportunities in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It provides financing for early and growth transactions to universities leading spin out and start up companies. It also makes co-investments. | Finance |
Manchester Imaging Ltd.
 Manchester Imaging Ltd. Packaged SoftwareTechnology Services Provides dental diagnostic software services | Technology Services |
Medherant Ltd.
 Medherant Ltd. Pharmaceuticals: MajorHealth Technology Develops transdermal drug delivery patches | Health Technology |
Cytomos Ltd.
Cytomos Ltd. Miscellaneous Commercial ServicesCommercial Services Provides rapid label-free cell analysis for biotech research and in-vitro diagnostics using dielectric spectroscopy | Commercial Services |
Invizius Ltd.
 Invizius Ltd. Packaged SoftwareTechnology Services Develops application for dialysis patients | Technology Services |
Cumulus Oncology Ltd.
Cumulus Oncology Ltd. Pharmaceuticals: MajorHealth Technology Develops oncology drugs | Health Technology |
Oskare Capital SAS
Oskare Capital SAS Investment ManagersFinance Oskare Capital SAS is an active manager that invests in Europe. | Finance |
Wobble Genomics Ltd.
 Wobble Genomics Ltd. Miscellaneous Commercial ServicesCommercial Services Develops DNA normalization technology which allows for maximum sampling efficiency during sequencing | Commercial Services |
Nodus Oncology Ltd.
Nodus Oncology Ltd. BiotechnologyHealth Technology Develops DDR targeting therapies | Health Technology |
Nicola Broughton Consulting Ltd. |
